Rangatira Investments is pleased to announce that John Chesterfield has been appointed to the role of CEO for Bio-Strategy.  This is a result of a detailed search over six months run by Spencer Stuart, a leading Australian Recruitment firm.

John is a seasoned executive having worked for ICI and then Orica over the last 30 years in a number of senior roles. He brings a wealth of experience and leadership in international sales and distribution. John has grown significant businesses through acquisition, sales and operations improvements both in Australia and offshore.  John is based in Melbourne, where he has a grown family.

We think he will be a great addition to Bio-Strategy and is well placed to lead the business through it's next phase of growth.

I would like to acknowledge the extensive contribution of Graeme Thompson to Bio-Strategy.  He was one of the founders of Bio-Strategy in 2003 and together with the strong team, he has built a great company and legacy that is well respected by suppliers, customers and the industry in New Zealand and Australia.  Bio-Strategy now has an excellent platform for the future.

Graeme will finish in his full-time capacity in November and remain on the Board as a non-executive Director and a significant shareholder.  

Mark Dossor
CEO Rangatira Investments

Rangatira Investments announces new CEO for Bio-Strategy

 
+ Text Size -
Original generation time 2.2046 seconds. Cache Loaded in: 0.0305 seconds.